G. Rahmathulla, N. F. Marko, and R. J. Weil, Cerebral radiation necrosis: a review of the pathobiology, diagnosis and management considerations, J Clin Neurosci, vol.20, pp.485-502, 2013.

J. Fink, D. Born, and M. C. Chamberlain, Radiation necrosis: relevance with respect to treatment of primary and secondary brain tumors, Curr Neurol Neurosci Rep, vol.12, pp.276-85, 2012.

D. Chi, A. Béhin, and J. Y. Delattre, Neurologic complications of radiation therapy, pp.259-86, 2008.

G. Minniti, E. Clarke, G. Lanzetta, M. F. Osti, G. Trasimeni et al., Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis, Radiat Oncol, vol.6, p.48, 2011.

T. Korytko, T. Radivoyevitch, V. Colussi, B. W. Wessels, K. Pillai et al., 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors, Int J Radiat Oncol, vol.64, pp.419-443, 2006.

J. L. Nakamura, L. J. Verhey, V. Smith, P. L. Petti, K. R. Lamborn et al., Dose conformity of gamma knife radiosurgery and risk factors for complications, Int J Radiat Oncol Biol Phys, vol.51, pp.1313-1322, 2001.

L. A. Nedzi, H. Kooy, A. E. Gelman, R. S. Loeffler, and J. S. , Variables associated with the development of complications from radiosurgery of intracranial tumors, Int J Radiat Oncol Biol Phys, vol.21, pp.591-600, 1991.

E. Shaw, C. Scott, L. Souhami, R. Dinapoli, R. Kline et al., Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05, Int J Radiat Oncol Biol Phys, vol.47, pp.291-299, 2000.

J. C. Flickinger, L. D. Lunsford, D. Kondziolka, A. H. Maitz, A. H. Epstein et al., Radiosurgery and brain tolerance: an analysis of neurodiagnostic imaging changes after gamma knife radiosurgery for arteriovenous malformations, Int J Radiat Oncol Biol Phys, vol.23, pp.19-26, 1992.

J. C. Flickinger, D. Kondziolka, L. D. Lunsford, A. Kassam, L. K. Phuong et al., Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients, Int J Radiat Oncol Biol Phys, vol.46, pp.1143-1151, 2000.

K. Ohtakara, S. Hayashi, N. Nakayama, N. Ohe, H. Yano et al., Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases, J Neurooncol, vol.108, pp.201-210, 2012.

J. D. Ruben, M. Dally, M. Bailey, R. Smith, C. A. Mclean et al., Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy, Int J Radiat Oncol Biol Phys, vol.65, pp.499-508, 2006.

C. A. Valéry, P. Cornu, G. Noël, M. Duyme, G. Boisserie et al., Predictive factors of radiation necrosis after radiosurgery for cerebral metastases, Stereotact Funct Neurosurg, vol.81, pp.115-124, 2003.

J. Voges, H. Treuer, V. Sturm, C. Büchner, R. Lehrke et al., Risk analysis of linear accelerator radiosurgery, Int J Radiat Oncol Biol Phys, vol.36, pp.1055-63, 1996.

B. J. Blonigen, R. D. Steinmetz, L. Levin, M. A. Lamba, R. E. Warnick et al., Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery, Int J Radiat Oncol Biol Phys, vol.77, pp.996-1001, 2010.

C. Wang, S. R. Floyd, C. Chang, P. C. Warnke, C. Chio et al., Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen, J Neurooncol, vol.106, pp.601-611, 2012.

G. Minniti, V. Esposito, C. E. Scaringi, C. Lanzetta, G. Salvati et al., Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases, Int J Radiat Oncol Biol Phys, vol.86, pp.623-632, 2013.

D. Karnofsky and J. H. Burchenal, The clinical evaluation of chemotherapeutic agents in cancer, pp.191-205, 1949.

L. Gaspar, C. Scott, M. Rotman, S. Asbell, T. Phillips et al., Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials, Int J Radiat Oncol Biol Phys, vol.37, pp.745-51, 1997.

L. Feuvret, G. Noël, J. J. Mazeron, and P. Bey, Conformity index: a review, Int J Radiat Oncol Biol Phys, vol.64, pp.333-375, 2006.

G. Noël, A. Tallet, G. Truc, V. Bernier, L. Feuvret et al., Radiothérapie encéphalique en totalité des métastases cérébrales : intérêts et controverses dans le cadre d'un référentiel, Cancer Radiother, vol.19, pp.30-35, 2015.

W. A. Friedman, F. J. Bova, S. Bollampally, and P. Bradshaw, Analysis of factors predictive of success or complications in arteriovenous malformation radiosurgery, Neurosurgery, vol.52, pp.296-307, 2003.

J. C. Flickinger, D. Kondziolka, B. E. Pollock, A. H. Maitz, and L. D. Lunsford, Complications from arteriovenous malformation radiosurgery: multivariate analysis and risk modeling, Int J Radiat Oncol Biol Phys, vol.38, pp.485-90, 1997.

G. Minniti, D. Angelillo, R. M. Scaringi, C. Trodella, L. E. et al., Fractionated stereotactic radiosurgery for patients with brain metastases, J Neurooncol, vol.117, pp.295-301, 2014.

H. K. Inoue, K. Seto, A. Nozaki, K. Torikai, Y. Suzuki et al., Three-fraction CyberKnife radiotherapy for brain metastases in critical areas: referring to the risk evaluating radiation necrosis and the surrounding brain volumes circumscribed with a single dose equivalence of 14 Gy (V14), J Radiat Res (Tokyo), vol.54, pp.727-762, 2013.

J. Gempt, J. Gerhardt, V. Toth, S. Hüttinger, Y. Ryang et al., Postoperative ischemic changes following brain metastasis resection as measured by diffusion-weighted magnetic resonance imaging, J Neurosurg, vol.119, pp.1395-400, 2013.

A. Ren, P. Gao, and Y. Sun, Correlation of MR imaging and histopathology after partial resection of normal rabbit brain, Chin Med J (Engl), vol.115, pp.247-53, 2002.

K. A. Ahmed, J. M. Freilich, Y. Abuodeh, N. Figura, N. Patel et al., Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases, J Neurooncol, vol.118, pp.179-86, 2014.

M. Doré, S. A. Martin, G. Delpon, L. Campion, and F. Thillays, Radiothérapie stéréotaxique postopératoire de métastase cérébrale : facteurs prédictifs de contrôle local et de radionécrose, Cancer Radiother, vol.21, pp.4-9, 2017.

. Al-omair, Hypofractionated stereotactic radiotherapy in five daily fractions for post-operative surgical cavities in brain metastases patients with and without prior whole brain radiation, Technol Cancer Res Treat, vol.12, pp.493-502, 2013.

B. Atalar, L. A. Modlin, C. Choi, J. R. Adler, I. C. Gibbs et al., Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases, Int J Radiat Oncol, vol.87, pp.713-721, 2013.

C. Brennan, T. J. Yang, P. Hilden, Z. Zhang, K. Chan et al., A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases, Int J Radiat Oncol Biol Phys, vol.88, pp.130-136, 2014.

D. C. Ling, J. A. Vargo, R. E. Wegner, J. C. Flickinger, S. A. Burton et al., Postoperative stereotactic radiosurgery to the resection cavity for large brain metastases: clinical outcomes, predictors of intracranial failure, and implications for optimal patient selection, Neurosurgery, vol.76, pp.150-157, 2015.

E. Ojerholm, J. Lee, J. P. Thawani, D. Miller, D. M. O'rourke et al., Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis, J Neurosurg, vol.121, pp.75-83, 2014.

N. Luther, D. Kondziolka, H. Kano, S. H. Mousavi, J. A. Engh et al., Predicting tumor control after resection bed radiosurgery of brain metastases, Neurosurgery, vol.73, pp.1001-1007, 2013.

J. Broemme, J. Abu-isa, R. Kottke, J. Beck, R. Wiest et al., Adjuvant therapy after resection of brain metastases: frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy, Strahlenther Onkol, vol.189, pp.765-70, 2013.

L. Do, R. Pezner, E. Radany, A. Liu, C. Staud et al., Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases, Int J Radiat Oncol Biol Phys, vol.73, pp.486-91, 2009.

C. A. Jensen, M. D. Chan, T. P. Mccoy, J. D. Bourland, A. F. Deguzman et al., Cavitydirected radiosurgery as adjuvant therapy after resection of a brain metastasis, J Neurosurg, vol.114, pp.1585-91, 2011.

C. Choi, S. D. Chang, I. C. Gibbs, J. R. Adler, G. R. Harsh et al., Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control, Int J Radiat Oncol Biol Phys, vol.84, pp.336-378, 2012.

R. Prabhu, H. Shu, C. Hadjipanayis, A. Dhabaan, W. Hall et al., Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control, Int J Radiat Oncol Biol Phys, vol.83, pp.61-67, 2012.

D. Steinmann, B. Maertens, S. Janssen, M. Werner, J. Frühauf et al., Hypofractionated stereotactic radiotherapy (hfSRT) after tumour resection of a single brain metastasis: report of a single-centre individualized treatment approach, J Cancer Res Clin Oncol, vol.138, pp.1523-1532, 2012.

J. R. Robbins, S. Ryu, S. Kalkanis, C. Cogan, J. Rock et al., Radiosurgery to the surgical cavity as adjuvant therapy for resected brain metastasis, Neurosurgery, vol.71, pp.937-980, 2012.

J. L. Sarrazin, Tumeurs de la fosse postérieure, J Radiol, vol.87, pp.748-63, 2006.

P. C. Bucy, Exposure of the posterior or cerebellar fossa, J Neurosurg, vol.24, pp.820-852, 1966.

C. E. Coles, A. C. Hoole, S. V. Harden, N. G. Burnet, N. Twyman et al., Quantitative assessment of inter-clinician variability of target volume delineation for medulloblastoma: quality assurance for the SIOP PNET 4 trial protocol, Radiother Oncol, vol.69, pp.189-94, 2003.

M. Doré, L. Lefebvre, G. Delpon, and F. Thillays, Radionécrose cérébrale après irradiation en conditions stéréotaxiques des berges opératoires : analyse de la littérature à partir de quatre cas, Cancer Radiother, vol.19, pp.111-120, 2015.

D. B. Almeida-freitas, M. C. Pinho, M. Otaduy, H. F. Braga, D. Meira-freitas et al., Assessment of irradiated brain metastases using dynamic contrastenhanced magnetic resonance imaging, Neuroradiology, vol.56, pp.437-480, 2014.

F. W. Hoefnagels, F. J. Lagerwaard, E. Sanchez, C. J. Haasbeek, D. L. Knol et al., Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence, J Neurol, vol.256, pp.878-87, 2009.

K. Mitsuya, Y. Nakasu, S. Horiguchi, H. Harada, T. Nishimura et al., Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery, J Neurooncol, vol.99, pp.81-89, 2010.

H. Zhang, L. Ma, Q. Wang, X. Zheng, C. Wu et al., Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: a systematic review and meta-analysis, Eur J Radiol, vol.83, pp.2181-2190, 2014.

J. Boström, D. R. Hadizadeh, W. Block, W. Willinek, H. H. Schild et al., Magnetic resonance spectroscopic study of radiogenic changes after radiosurgery of cerebral arteriovenous malformations with implications for the differential diagnosis of radionecrosis, Radiat Oncol, vol.8, p.54, 2013.

P. Weybright, P. C. Sundgren, P. Maly, D. G. Hassan, B. Nan et al., Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy, AJR Am J Roentgenol, vol.185, pp.1471-1477, 2005.

A. K. Demetriades, A. C. Almeida, R. S. Bhangoo, and S. F. Barrington, Applications of positron emission tomography in neuro-oncology: a clinical approach, Surgeon, vol.12, pp.148-57, 2014.

S. T. Chao, J. H. Suh, S. Raja, S. Y. Lee, and G. Barnett, The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery, Int J Cancer, vol.96, pp.191-198, 2001.

J. Matuszak, W. Waissi, J. B. Clavier, G. Noël, and I. J. Namer, Métastases cérébrales : apport de l'acquisition tardive en TEP/TDM au (18F)-FDG pour le diagnostic différentiel entre récurrence tumorale et radionécrose, Med Nucl, vol.40, 0196.

K. J. Lizarraga, M. Allen-auerbach, J. Czernin, A. Desalles, W. H. Yong et al., 18F)-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment, J Nucl Med, vol.55, pp.30-36, 2014.

W. Chen, D. H. Silverman, S. Delaloye, J. Czernin, N. Kamdar et al., 18F)FDOPA PET imaging of brain tumors: comparison study with (18F)-FDG PET and evaluation of diagnostic accuracy, J Nucl Med, vol.47, pp.904-915, 2006.

T. Serizawa, N. Saeki, Y. Higuchi, J. Ono, S. Matsuda et al., Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after gamma knife surgery for metastatic brain tumors, J Neurosurg, vol.102, pp.266-71, 2005.

I. Menoux, J. Armspach, G. Noël, and A. D. , Techniques d'imagerie utilisées dans le diagnostic différentiel entre radionécrose cérébrale et rechute tumorale après irradiation en conditions stéréotaxiques de métastases cérébrales : revue de la littérature, Cancer Radiother, vol.20, pp.837-882, 2016.

S. T. Chao, M. S. Ahluwalia, G. H. Barnett, G. H. Stevens, E. S. Murphy et al., Challenges with the diagnosis and treatment of cerebral radiation necrosis, Int J Radiat Oncol Biol Phys, vol.87, pp.449-57, 2013.

Y. Yoshii, Pathological review of late cerebral radionecrosis, Brain Tumor Pathol, vol.25, pp.51-59, 2008.

P. C. Burger and O. B. Boyko, The pathology of central nervous system radiation injury, pp.191-208, 1991.

B. T. Ragel, T. C. Ryken, S. N. Kalkanis, M. Ziu, D. Cahill et al., The role of biopsy in the management of patients with presumed diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline, J Neurooncol, vol.125, pp.481-501, 2015.

C. Soussain, D. Ricard, J. R. Fike, J. Mazeron, D. Psimaras et al., CNS complications of radiotherapy and chemotherapy, Lancet, vol.374, p.61299, 2009.